Bio-Techne (TECH) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bio-Techne Releases Second Quarter Fiscal 2017 Results
February 7, 2017 7:30 AM ESTMINNEAPOLIS, Feb. 7, 2017 /PRNewswire/ --Â Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2016.
Second Quarter FY2017 Snapshot
Second quarter revenue increased by 9% to $131.8 million. GAAP fully diluted earnings per share (EPS) for the second quarter decreased 75% to $0.17 due to acquisition-related amortization, contingent consideration fair value adjustments, and other acquisition related costs. Delivered second quarter adjusted earnings per share (EPS) of $0.81, a decrease of 8% from the prior year, with foreign... More